• Study on Long-Term Safety of Secukinumab for Patients with Psoriatic Arthritis, Ankylosing Spondylitis, and Severe Chronic Plaque Psoriasis

    Recruiting

    3 1 1 1 1
    Investigated Drugs:
    Belgium Bulgaria Czechia France Germany Italy +3

  • Phase 1/2 Study of pumitamig Alone or Combined with ipilimumab or cabozantinib in Patients with Advanced Renal Cell Carcinoma

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    Czechia Finland

  • A Randomized Dose‑Ranging Study of Nalbuphine Hydrochloride Extended‑Release Tablets in Adults with Refractory Chronic Cough

    Not yet recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Poland

  • Safety and Efficacy of Two Doses of OCUL101 Compared with Aflibercept in Patients with Neovascular Age‑Related Macular Degeneration

    Not yet recruiting

    4 1 1 1
    Investigated Drugs:
    Czechia Hungary Latvia Poland

  • Efficacy and safety of the investigational mRNA influenza vaccine gskvx000000077430 (drug combination) in adults ≥ 65 years

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Finland Germany

  • Study of the safety and immune response of gskvx000000077430 drug combination versus standard influenza vaccine in adults 18‑64 years

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Germany

  • Study of Sacituzumab Tirumotecan in Patients with Papillary Renal Cell Carcinoma and Variant Histology Urothelial Carcinoma (Rare Genitourinary Tumors)

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Phase 2b Study of ATH-063 in Adults with Biologic‑Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis

    Not yet recruiting

    2 1
    Investigated Diseases:
    Poland

  • Safety and efficacy of elfucose, d‑galactose and polyhexanide solution 20% in patients with chronic wounds colonized by Pseudomonas aeruginosa

    Not yet recruiting

    2 1 1 1
    Germany

  • Efficacy and Safety of Olatorepatide in Adults with Overweight or Obesity and Type 2 Diabetes

    Not yet recruiting

    3 1
    Investigated Diseases:
    Germany Hungary

powered by